China · Delayed Price · Currency is CNY Regulus Therapeutics Statistics
Total Valuation
SHA:601288 has a market cap or net worth of CNY 2.17 trillion.
| Market Cap | 2.17T |
| Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Saturday, August 30, 2025.
| Earnings Date | Aug 30, 2025 |
| Ex-Dividend Date | Jul 17, 2025 |
Share Statistics
| Current Share Class | 319.24B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.32% |
| Shares Change (QoQ) | +50.52% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 199.67B |
Valuation Ratios
The trailing PE ratio is 8.19 and the forward PE ratio is 7.82.
| PE Ratio | 8.19 |
| Forward PE | 7.82 |
| PS Ratio | 3.73 |
| PB Ratio | 0.69 |
| P/TBV Ratio | 0.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.20 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.25%.
| Return on Equity (ROE) | 9.25% |
| Return on Assets (ROA) | 0.65% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 1.27M |
| Profits Per Employee | 581,341 |
| Employee Count | 454,716 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SHA:601288 has paid 33.46 billion in taxes.
| Income Tax | 33.46B |
| Effective Tax Rate | 10.54% |
Stock Price Statistics
The stock price has increased by +37.91% in the last 52 weeks. The beta is 0.27, so SHA:601288's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | +37.91% |
| 50-Day Moving Average | 5.92 |
| 200-Day Moving Average | 5.31 |
| Relative Strength Index (RSI) | 63.03 |
| Average Volume (20 Days) | 467,432,391 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:601288 had revenue of CNY 579.72 billion and earned 264.35 billion in profits. Earnings per share was 0.75.
| Revenue | 579.72B |
| Gross Profit | 579.72B |
| Operating Income | 317.27B |
| Pretax Income | 317.41B |
| Net Income | 264.35B |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 0.75 |
Balance Sheet
The company has 3.62 trillion in cash and 5.08 trillion in debt, giving a net cash position of -1,453.75 billion.
| Cash & Cash Equivalents | 3.62T |
| Total Debt | 5.08T |
| Net Cash | -1,453.75B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.14T |
| Book Value Per Share | 7.54 |
| Working Capital | -32,124.17B |
Cash Flow
In the last 12 months, operating cash flow was -1,562.67 billion and capital expenditures -23.64 billion, giving a free cash flow of -1,586.32 billion.
| Operating Cash Flow | -1,562.67B |
| Capital Expenditures | -23.64B |
| Free Cash Flow | -1,586.32B |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 54.73% |
| Pretax Margin | 54.75% |
| Profit Margin | 48.93% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.24, which amounts to a dividend yield of 3.80%.
| Dividend Per Share | 0.24 |
| Dividend Yield | 3.80% |
| Dividend Growth (YoY) | 4.76% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 50.04% |
| Buyback Yield | 0.32% |
| Shareholder Yield | 4.13% |
| Earnings Yield | 12.21% |
| FCF Yield | -73.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |